NA In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030

NA In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030


The North America in-vitro toxicology testing market is expected to reach USD 11,902.69 Million by 2030 from USD 4,163.02 Million in 2022, growing at a CAGR of 14.0% during the forecast period of 2023 to 2030.

Market Segmentation

North America In-Vitro Toxicology Testing Market, By Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (Adme (Absorption, Distribution, Metabolism, & Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, & Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture Technologies, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics & Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of North America In-Vitro Toxicology Testing Market Dynamics:

Driver

• Rising investment in R&D by key market players
Restrain

• Complexity of biological systems

Opportunity

• Technological advancements to develop new toxicology testing methods

Market Players
Some of the major market players operating in the North America in-vitro toxicology testing market are:
• Thermo Fisher Scientific Inc.
• Labcorp Drug Development
• Merck KGaA
• Charles River Laboratories
• Lonza
• Eurofins Scientific
• SGS Société Générale de Surveillance SA
• Bio-Rad Laboratories, Inc.
• QIAGEN
• Cyprotex Plc.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America In-vitro Toxicology Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Product And Service Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porters Analysis
5 North America In-vitro Toxicology Testing Market, Industry Insights
6 North America In-vitro Toxicology Testing Market, Regulations
7 Market Overview
7.1 Drivers
7.1.1 Increasing Demand For Toxicology Testing Products
7.1.2 Rapidly Growing Pharmaceutical And Medical Device Industries
7.1.3 Rising Investment In R&D By Key Market Players
7.1.4 Technological Advancements To Develop New Toxicology Testing Methods
7.2 Restraints
7.2.1 High Costs Associated With In-vitro Toxicology Testing And Products
7.2.2 Complexity Of Biological Systems
7.2.3 Need For Skilled Personnel And Infrastructure
7.3 Opportunities
7.3.1 Growing Adoption Of Quality Check Products To Prevent Product Recalls
7.3.2 Strategic Initiatives By Key Market Players For Market Expansion
7.3.3 Growing Demand For Personalized Medicine And Precision Toxicology
7.4 Challenges
7.4.1 Ethical And Public Perception
7.4.2 Regulatory Acceptance And Endorsement Of In-vitro Testing Methods
8 North America In-vitro Toxicology Testing Market, By Product And Service
8.1 Overview
8.2 Consumables
8.3 Services
8.3.1 Cytotoxicity
8.3.2 Gene Toxicity
8.3.3 Hepatotoxicity
8.3.4 Ophthalmic Toxicity
8.3.5 Cardiotoxicity
8.3.6 Nephrotoxicity
8.3.7 Neurotoxicity
8.3.8 Others
8.4 Assays
8.4.1 Cell-based Elisa & Western Blots
8.4.2 Enzyme Toxicity Assays
8.4.3 Receptor-binding Assays
8.4.4 Bacterial Toxicity Assays
8.4.5 Tissue Culture Assays
8.4.6 Other Assays
8.5 Equipments
8.6 Software
9 North America In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test
9.1 Overview
9.2 Adme (Absorption, Distribution, Metabolism, & Excretion) Testing
9.3 Cytotoxicity Testing
9.4 Genotoxicity Testing
9.5 Dermal Toxicity Testing
9.6 Ocular Toxicity Testing
9.7 Organ Toxicity Testing
9.8 Skin Irritation, Corrosion, & Sensitization Testing
9.9 Phototoxicity Testing
9.10 Other Toxicity Endpoints And Tests
10 North America In-vitro Toxicology Testing Market, By Technology
10.1 Overview
10.2 Cell Culture Technologies
10.3 High-throughput Technologies
10.4 Molecular Imaging
10.5 Omics Technology
11 North America In-vitro Toxicology Testing Market, By Method
11.1 Overview
11.2 Cellular Assays
11.3 Biochemical Assays
11.4 Ex-vivo Models
11.5 In Silico Models
12 North America In-vitro Toxicology Testing Market, By Industry
12.1 Overview
12.2 Pharmaceutical And Biopharmaceutical Companies
12.2.1 Consumables
12.2.2 Services
12.2.3 Assays
12.2.4 Equipments
12.2.5 Software
12.3 Diagnostics
12.3.1 Consumables
12.3.2 Services
12.3.3 Assays
12.3.4 Equipments
12.3.5 Software
12.4 Food
12.4.1 Consumables
12.4.2 Service
12.4.3 Assays
12.4.4 Equipments
12.4.5 Software
12.5 Chemicals
12.5.1 Consumables
12.5.2 Services
12.5.3 Assays
12.5.4 Equipments
12.5.5 Software
12.6 Cosmetics And Household Products
12.6.1 Consumables
12.6.2 Services
12.6.3 Assays
12.6.4 Equipments
12.6.5 Software
13 North America In-vitro Toxicology Testing Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.4 Others
14 North America In-vitro Toxicology Testing Market, By Region
14.1 North America
14.1.1 U.S.
14.1.2 Canada
14.1.3 Mexico
15 North America In-vitro Toxicology Testing Market, Company Landscape
15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile
17.1 Thermo Fisher Scientific Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Labcorp Drug Development
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Merck Kgaa
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Charles River Laboratories.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Lonza
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Aat Bioquest, Inc.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Developments
17.7 Aragen Life Sciences Ltd.
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Bioivt
17.8.1 Company Snapshot
17.8.2 Product Portfolio
17.8.3 Recent Development
17.9 Bio-rad Laboratories, Inc.
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Development
17.10 Catalent, Inc
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Creative Bioarray.
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Developments
17.12 Creative Biolabs.
17.12.1 Company Snapshot
17.12.2 Product Portfolio
17.12.3 Recent Developments
17.13 Cyprotex Limited
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Eurofins Scientific
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Gentronix
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Iontox
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
17.17 Insphero.
17.17.1 Company Snapshot
17.17.2 Product Portfolio
17.17.3 Recent Development
17.18 Intertek Group Plc
17.18.1 Company Snapshot
17.18.2 Revenue Analysis
17.18.3 Product Portfolio
17.18.4 Recent Development
17.19 Mb Research Laboratories
17.19.1 Company Snapshot
17.19.2 Product Portfolio
17.19.3 Recent Developments
17.20 Preferred Cell Systems
17.20.1 Company Snapshot
17.20.2 Product Portfolio
17.20.3 Recent Developments
17.21 Promega Corporation
17.21.1 Company Snapshot
17.21.2 Product Portfolio
17.21.3 Recent Developments
17.22 Qiagen
17.22.1 Company Snapshot
17.22.2 Revenue Analysis
17.22.3 Product Portfolio
17.22.4 Recent Developments
17.23 Sgs Société Générale De Surveillance Sa
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Product Portfolio
17.23.4 Recent Developments
17.24 Shanghai Medicilon Inc.
17.24.1 Company Snapshot
17.24.2 Revenue Analysis
17.24.3 Product Portfolio
17.24.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 North America In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 2 North America Consumables In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 3 North America Services In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 4 North America Services In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 5 North America Assays In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 6 North America Assays In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 7 North America Equipment In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 8 North America Software In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 9 North America In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test, 2021-2030 (Usd Million)
Table 10 North America Adme (Absorption, Distribution, Metabolism, & Excretion) Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 11 North America Cytotoxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 12 North America Genotoxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 13 North America Dermal Toxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 14 North America Ocular Toxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Organ Toxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 16 North America Skin Irritation, Corrosion, & Sensitization Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 17 North America Phototoxicity Testing In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 18 North America Other Toxicity Endpoints And Tests In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 19 North America In-vitro Toxicology Testing Market, By Technology, 2021-2030 (Usd Million)
Table 20 North America Cell Culture Technologies In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 21 North America High-throughput Technologies In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 22 North America Molecular Imaging In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Omics Technology In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 24 North America In-vitro Toxicology Testing Market, By Method, 2021-2030 (Usd Million)
Table 25 North America Cellular Assays In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 26 North America Biochemical Assays In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 27 North America Ex-vivo Models In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 28 North America In Silico Models In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 29 North America In-vitro Toxicology Testing Market, By Industry, 2021-2030 (Usd Million)
Table 30 North America Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 31 North America Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 32 North America Diagnostics In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 33 North America Diagnostics In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 34 North America Food In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 35 North America Food In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 36 North America Chemicals In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 37 North America Chemicals In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 38 North America Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 39 North America Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 40 North America In-vitro Toxicology Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 41 North America Direct Tender In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 42 North America Retail Sales In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 43 North America Others In In-vitro Toxicology Testing Market, By Region, 2021-2030 (Usd Million)
Table 44 North America In-vitro Toxicology Testing Market, By Country, 2021-2030 (Usd Million)
Table 45 North America In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 46 North America Services In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 47 North America Assays In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 48 North America In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test, 2021-2030 (Usd Million)
Table 49 North America In-vitro Toxicology Testing Market, By Technology, 2021-2030 (Usd Million)
Table 50 North America In-vitro Toxicology Testing Market, By Method, 2021-2030 (Usd Million)
Table 51 North America In-vitro Toxicology Testing Market, By Industry, 2021-2030 (Usd Million)
Table 52 North America Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 53 North America Diagnostics In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 54 North America Food In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 55 North America Chemicals In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 56 North America Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 57 North America In-vitro Toxicology Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 58 U.S. In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 59 U.S. Services In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 60 U.S. Assays In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 61 U.S. In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test, 2021-2030 (Usd Million)
Table 62 U.S. In-vitro Toxicology Testing Market, By Technology, 2021-2030 (Usd Million)
Table 63 U.S. In-vitro Toxicology Testing Market, By Method, 2021-2030 (Usd Million)
Table 64 U.S. In-vitro Toxicology Testing Market, By Industry, 2021-2030 (Usd Million)
Table 65 U.S. Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 66 U.S. Diagnostics In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 67 U.S. Food In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 68 U.S. Chemicals In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 69 U.S. Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 70 U.S. In-vitro Toxicology Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 71 Canada In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 72 Canada Services In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 73 Canada Assays In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 74 Canada In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test, 2021-2030 (Usd Million)
Table 75 Canada In-vitro Toxicology Testing Market, By Technology, 2021-2030 (Usd Million)
Table 76 Canada In-vitro Toxicology Testing Market, By Method, 2021-2030 (Usd Million)
Table 77 Canada In-vitro Toxicology Testing Market, By Industry, 2021-2030 (Usd Million)
Table 78 Canada Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 79 Canada Diagnostics In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 80 Canada Food In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 81 Canada Chemicals In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 82 Canada Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 83 Canada In-vitro Toxicology Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 84 Mexico In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 85 Mexico Services In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 86 Mexico Assays In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 87 Mexico In-vitro Toxicology Testing Market, By Toxicology Endpoint And Test, 2021-2030 (Usd Million)
Table 88 Mexico In-vitro Toxicology Testing Market, By Technology, 2021-2030 (Usd Million)
Table 89 Mexico In-vitro Toxicology Testing Market, By Method, 2021-2030 (Usd Million)
Table 90 Mexico In-vitro Toxicology Testing Market, By Industry, 2021-2030 (Usd Million)
Table 91 Mexico Pharmaceutical & Biopharmaceutical Companies In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 92 Mexico Diagnostics In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 93 Mexico Food In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 94 Mexico Chemicals In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 95 Mexico Cosmetics & Household Products In In-vitro Toxicology Testing Market, By Product And Service, 2021-2030 (Usd Million)
Table 96 Mexico In-vitro Toxicology Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 North America In-vitro Toxicology Testing Market: Segmentation
Figure 2 North America In-vitro Toxicology Testing Market: Data Triangulation
Figure 3 North America In-vitro Toxicology Testing Market: Droc Analysis
Figure 4 North America In-vitro Toxicology Testing Market: North America Vs Regional Market Analysis
Figure 5 North America In-vitro Toxicology Testing Market: Company Research Analysis
Figure 6 North America In-vitro Toxicology Testing Market: Interview Demographics
Figure 7 North America In-vitro Toxicology Testing Market: Market End User Coverage Grid
Figure 8 North America In-vitro Toxicology Testing Market: Dbmr Market Position Grid
Figure 9 North America In-vitro Toxicology Testing Market: Vendor Share Analysis
Figure 10 North America In-vitro Toxicology Testing Market: Segmentation
Figure 11 Rising Demand For Toxicology Testing Products And Rapidly Growing Pharmaceutical And Medical Industries Are Expected To Drive The Growth Of The North America In-vitro Toxicology Testing Market From 2023 To 2030
Figure 12 The Consumables Segment, Is Expected To Account For The Largest Share Of The North America In-vitro Toxicology Testing Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America In-vitro Toxicology Testing Market
Figure 14 North America In-vitro Toxicology Testing Market: By Product And Service, 2022
Figure 15 North America In-vitro Toxicology Testing Market: By Product And Service, 2023-2030 (Usd Million)
Figure 16 North America In-vitro Toxicology Testing Market: By Product And Service, Cagr (2023-2030)
Figure 17 North America In-vitro Toxicology Testing Market: By Product And Service, Lifeline Curve
Figure 18 North America In-vitro Toxicology Testing Market: By Toxicology Endpoint And Test, 2022
Figure 19 North America In-vitro Toxicology Testing Market: By Toxicology Endpoint And Test, 2020-2029 (Usd Million)
Figure 20 North America In-vitro Toxicology Testing Market: By Toxicology Endpoint And Test, Cagr (2023-2030)
Figure 21 North America In-vitro Toxicology Testing Market: By Toxicology Endpoint And Test, Lifeline Curve
Figure 22 North America In-vitro Toxicology Testing Market: By Technology, 2022
Figure 23 North America In-vitro Toxicology Testing Market: By Technology, 2023-2030 (Usd Million)
Figure 24 North America In-vitro Toxicology Testing Market: By Technology, Cagr (2023-2030)
Figure 25 North America In-vitro Toxicology Testing Market: By Technology, Lifeline Curve
Figure 26 North America In-vitro Toxicology Testing Market: By Method, 2022
Figure 27 North America In-vitro Toxicology Testing Market: By Method, 2023-2030 (Usd Million)
Figure 28 North America In-vitro Toxicology Testing Market: By Method, Cagr (2023-2030)
Figure 29 North America In-vitro Toxicology Testing Market: By Method, Lifeline Curve
Figure 30 North America In-vitro Toxicology Testing Market: By Industry, 2022
Figure 31 North America In-vitro Toxicology Testing Market: By Industry, 2023-2030 (Usd Million)
Figure 32 North America In-vitro Toxicology Testing Market: By Industry, Cagr (2023-2030)
Figure 33 North America In-vitro Toxicology Testing Market: By Industry, Lifeline Curve
Figure 34 North America In-vitro Toxicology Testing Market: By Distribution Channel, 2022
Figure 35 North America In-vitro Toxicology Testing Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 36 North America In-vitro Toxicology Testing Market: By Distribution Channel, Cagr (2023-2030)
Figure 37 North America In-vitro Toxicology Testing Market: By Distribution Channel, Lifeline Curve
Figure 38 North America In-vitro Toxicology Testing Market: Snapshot (2022)
Figure 39 North America In-vitro Toxicology Testing Market: By Country (2022)
Figure 40 North America In-vitro Toxicology Testing Market: By Country (2023 & 2030)
Figure 41 North America In-vitro Toxicology Testing Market: By Country (2022 & 2030)
Figure 42 North America In-vitro Toxicology Testing Market: By Product And Service (2023-2030)
Figure 43 North America In-vitro Toxicology Testing Market: Company Share 2022 (%) 138

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings